Cargando…

A pH-dependent anti-CD47 antibody that selectively targets solid tumors and improves therapeutic efficacy and safety

BACKGROUND: The antiphagocytic molecule CD47 is overexpressed in a wide variety of cancer cells, and antibodies targeting CD47 for cancer therapies are currently under intensive investigation. However, owing to the ubiquitous expression of CD47 on healthy cells, anti-CD47 therapies often achieve onl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yulu, Liu, Juan, Chen, Wei, Wang, Wei, Yang, Fang, Liu, Ximing, Sheng, Yao, Du, Kaixin, He, Miaomiao, Lyu, Xueyuan, Li, Huiyu, Zhao, Linlin, Wei, Zhizhong, Wang, Fengchao, Zheng, Sanduo, Sui, Jianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844003/ https://www.ncbi.nlm.nih.gov/pubmed/36650558 http://dx.doi.org/10.1186/s13045-023-01399-4

Ejemplares similares

Novel Abs targeting the N‐terminus of fibroblast growth factor 19 inhibit hepatocellular carcinoma growth without bile‐acid‐related side‐effects
por: Liu, Huisi, et al.
Publicado: (2020)

A cross-reactive pH-dependent EGFR antibody with improved tumor selectivity and penetration obtained by structure-guided engineering
por: Liu, Ximing, et al.
Publicado: (2022)

A potent human neutralizing antibody Fc-dependently reduces established HBV infections
por: Li, Dan, et al.
Publicado: (2017)

Development and Characterization of Nanobody-Derived CD47 Theranostic Pairs in Solid Tumors
por: Zhang, You, et al.
Publicado: (2023)

The application of HER2 and CD47 CAR-macrophage in ovarian cancer
por: Chen, Yizhao, et al.
Publicado: (2023)

Memorandum: PH 3 - 70/47
por: Michaelis, E G
Publicado: (1970)

CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis
por: Liu, Ran, et al.
Publicado: (2017)

The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
por: Shi, Rui, et al.
Publicado: (2020)

Enhanced tumor immunotherapy by polyfunctional CD19-CAR T cells engineered to secrete anti-CD47 single-chain variable fragment
por: Qiu, Yingqi, et al.
Publicado: (2023)

EGFR‐Induced and c‐Src‐Mediated CD47 Phosphorylation Inhibits TRIM21‐Dependent Polyubiquitylation and Degradation of CD47 to Promote Tumor Immune Evasion
por: Du, Linyong, et al.
Publicado: (2023)

Promising alternatives of CD47 monoclonal antibody: an injectable degradable hydrogel loaded with PQ912 for postoperative immunotherapy effectively blocks CD47-SIRPα signal
por: Li, Chang, et al.
Publicado: (2022)

Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma
por: Wu, Hao, et al.
Publicado: (2021)

Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex
por: Sun, Fei-Ji, et al.
Publicado: (2016)

IMM0306, a fusion protein of CD20 mAb with the CD47 binding domain of SIRPα, exerts excellent cancer killing efficacy by activating both macrophages and NK cells via blockade of CD47-SIRPα interaction and FcɣR engagement by simultaneously binding to CD47 and CD20 of B cells
por: Yu, Jifeng, et al.
Publicado: (2022)

Is CD47 an innate immune checkpoint for tumor evasion?
por: Liu, Xiaojuan, et al.
Publicado: (2017)

Role of CD47 in Hematological Malignancies
por: Eladl, Entsar, et al.
Publicado: (2020)

CD47/SIRPα pathway mediates cancer immune escape and immunotherapy
por: Jia, Xiao, et al.
Publicado: (2021)

CD47 cross-dressing by extracellular vesicles expressing CD47 inhibits phagocytosis without transmitting cell death signals
por: Li, Yang, et al.
Publicado: (2022)

A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer
por: Lin, Fangzhen, et al.
Publicado: (2021)

CD47 on artificial structures
por: Schütz, Christian
Publicado: (2015)

Regulation of CD47 expression by interferon-gamma in cancer cells
por: Ye, Zi-Han, et al.
Publicado: (2021)

Positive tumour CD47 expression is an independent prognostic factor for recurrence in resected non-small cell lung cancer
por: Xu, Yan, et al.
Publicado: (2020)

Evaluation of CD47 in the Suppressive Tumor Microenvironment and Immunotherapy in Prostate Cancer
por: Wang, Qianqian, et al.
Publicado: (2023)

CD47 differentially regulates white and brown fat function
por: Norman-Burgdolf, Heather, et al.
Publicado: (2020)

Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell Carcinoma
por: Wang, Huimin, et al.
Publicado: (2015)

Vaccination with CD47 deficient tumor cells elicits an antitumor immune response in mice
por: Li, Yang, et al.
Publicado: (2020)

Construction of Exosomes that Overexpress CD47 and Evaluation of Their Immune Escape
por: Ben, Xin-Yu, et al.
Publicado: (2022)

Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma
por: Wang, Jian‐Hua, et al.
Publicado: (2019)

CD47-Blocking Antibodies and Atherosclerosis
por: Ryan, John J.
Publicado: (2016)

Targeting CD47 for cancer immunotherapy
por: Jiang, Zhongxing, et al.
Publicado: (2021)

Delivery of CD47 blocker SIRPα-Fc by CAR-T cells enhances antitumor efficacy
por: Chen, Huanpeng, et al.
Publicado: (2022)

Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
por: Liu, Liang, et al.
Publicado: (2017)

The ionophore antibiotic gramicidin A inhibits pancreatic cancer stem cells associated with CD47 down-regulation
por: Wang, Rui-Qi, et al.
Publicado: (2019)

MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47
por: Huang, Wei, et al.
Publicado: (2018)

Role of CD47 in tumor immunity: a potential target for combination therapy
por: Huang, Jing, et al.
Publicado: (2022)

VLM catecholaminergic neurons control tumor growth by regulating CD8(+) T cells
por: Zhang, Ze, et al.
Publicado: (2021)

A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
por: Betancur, Paola A., et al.
Publicado: (2017)

Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer
por: Cao, Xu, et al.
Publicado: (2021)

Expression of CD47 in Endometrial Cancer and Its Clinicopathological Significance
por: Yang, Mei, et al.
Publicado: (2022)

CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer
por: Zhao, Hui, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1534btj8qf69ureqkcdhiqdjis